Concepedia

Recurrence Risk Reduction

Recurrence Risk Reduction is a clinical outcome metric that quantifies the extent to which neoadjuvant immunotherapy decreases the likelihood of cancer relapse following primary treatment compared to untreated or differently treated cohorts.

290

Publications

17.2K

Citations

2.1K

Authors

810

Institutions

Publications per year

2017–2026

112

Parents

Publications

290

Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection

Chun‐Ying Wu, Yi–Ju Chen, Hsiu J. Ho et al. · JAMA · 2012 · 828 citations

, , +14

Aspirin for Preventing the Recurrence of Venous Thromboembolism

Cecilia Becattini, Giancarlo Agnelli, Alessandro Schenone et al. · New England Journal of Medicine · 2012 · 619 citations · Full text

, , +17

From normal response to clinical problem: definition and clinical features of fear of cancer recurrence

Sophie Lebel, Gözde Özakinci, Brittany Mutsaers et al. · Supportive Care in Cancer · 2016 · 585 citations

, , +16

Vitamin D, Calcium Supplementation, and Colorectal Adenomas: Results of a Randomized Trial

Maria V. Grau · JNCI Journal of the National Cancer Institute · 2003 · 378 citations

, , +17

Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.

Alexander Marzuka, Samuel E Book · PubMed · 2015 · 377 citations

, , +17

1–5 of 290

Authors

2.1K

  1. PB
    Phyllis Butow

    The University of Sydney, Australia

    5 publications · 800 citations

    5

    h-index

  2. BT
    Belinda Thewes

    The University of Sydney, Australia

    4 publications · 775 citations

    4

    h-index

  3. PR
    Piotr Rutkowski

    The Maria Sklodowska-Curie National Research Institute of Oncology, Poland

    4 publications · 324 citations

    4

    h-index

  4. JL
    Jo‐Fen Liu

    University of Nottingham, United Kingdom

    4 publications · 141 citations

    4

    h-index

  5. KM
    Kenneth Muir

    Institute of Cancer Research, United Kingdom

    4 publications · 141 citations

    4

    h-index

1–5 of 2.1K

Institutions

810

  1. The University of Sydney

    Sydney, Australia

    12 h-index

    54 publications

    2.8K citations

  2. Radboud University Nijmegen

    Nijmegen, The Netherlands

    11 h-index

    24 publications

    2.6K citations

  3. Memorial Sloan Kettering Cancer Center

    New York, United States

    8 h-index

    32 publications

    1.1K citations

  4. Cleveland Clinic

    Cleveland, United States

    7 h-index

    24 publications

    3.4K citations

  5. University of Nottingham

    Nottingham, United Kingdom

    7 h-index

    29 publications

    1.2K citations

  6. Harvard University

    Cambridge, United States

    7 h-index

    14 publications

    778 citations

  7. University of North Carolina at Chapel Hill

    Chapel Hill, United States

    7 h-index

    22 publications

    1.2K citations

  8. The University of Texas MD Anderson Cancer Center

    Houston, United States

    7 h-index

    36 publications

    3K citations

1–8 of 810

Venues

  1. Journal of Clinical Oncology

    21 publications · 1.6K citations

    14

    h-index

  2. PubMed

    Repository · 16 publications · 857 citations

    13

    h-index

  3. Breast Cancer Research and Treatment

    6 publications · 290 citations

    6

    h-index

  4. Cancer Epidemiology Biomarkers & Prevention

    CEBP · 6 publications · 357 citations

    6

    h-index

  5. Annals of Oncology

    5 publications · 403 citations

    5

    h-index

1–5